In conclusion, our case broadens the phenotypic spectrum of SPATA5L1-related disease, confirms its overlap with but distinction from SPATA5-related disorder, and emphasizes the need for early, multidimensional assessment in children presenting with unexplained psychomotor delay. The gene discussed is AFG2B; the disease is Global developmental delay.